A Study of IMR-687 in Healthy Adult Volunteers

Clinical trial NCT02998450 · COMPLETED

Trial details

NCT number: NCT02998450
Sponsor: Cardurion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle-Cell; Hb-SC Sickle Beta 0 Thalassemia

Start date: 2016-10-18
Primary completion: 2017-07-08
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.